What is the appropriate evaluation and management for a patient who had a coronary stent placed two days ago and is now experiencing hypotension?

Immediate Evaluation for Post-PCI Hypotension

This patient requires urgent evaluation for life-threatening complications including stent thrombosis, bleeding (retroperitoneal hematoma, access site), cardiac tamponade, or intramural hematoma—all of which can present with hypotension 2 days post-stent placement.

Critical Initial Assessment

Hypotension occurring 2 days after coronary stenting represents a high-risk scenario requiring immediate systematic evaluation. The timing places this patient in the highest-risk window for subacute stent thrombosis, which carries 20-45% mortality 1.

Immediate Diagnostic Priorities

First-line evaluation must include:

• 12-lead ECG - Look specifically for new ST-segment elevation, T-wave inversions, or Q-waves suggesting acute stent thrombosis or MI

• Troponin level - Elevated troponin indicates myocardial injury from possible stent thrombosis

• Complete blood count - Assess for acute blood loss anemia from occult bleeding

• Bedside echocardiography - Evaluate for:

  • Pericardial effusion/tamponade
  • New wall motion abnormalities (stent thrombosis)
  • LV function deterioration
  • Intramural hematoma (rare but catastrophic) 2

• Groin/access site examination - Palpate for expanding hematoma, check distal pulses, assess for retroperitoneal bleeding (flank ecchymosis, abdominal distension)

High-Risk Differential Diagnoses

1. Stent Thrombosis (Most Critical)

• Occurs in approximately 1% of cases in the early post-PCI period 1
• Results in death or MI in 64.4% of cases 1
• Verify DAPT compliance immediately - Premature discontinuation markedly increases thrombosis risk 1
• If suspected: Emergency cardiac catheterization is required

2. Bleeding Complications

• Retroperitoneal hematoma (especially with femoral access)
• Access site bleeding
• GI bleeding (particularly if on DAPT)
• CT abdomen/pelvis if hemoglobin drop without obvious source

3. Cardiac Tamponade

• Can occur from coronary perforation during PCI
• Echocardiography is diagnostic
• Requires urgent pericardiocentesis

4. Intramural Hematoma

• Rare but potentially fatal complication causing "pseudotamponade" 2
• CT or cardiac MRI for diagnosis
• May require hemodynamic support with intra-aortic balloon pump

Management Algorithm

Hemodynamic Support Strategy

Initial resuscitation:

• Intravenous fluid bolus (500-1000 mL crystalloid) unless evidence of cardiogenic shock or tamponade
• Hold antihypertensive medications immediately
• Continue DAPT - Do NOT stop aspirin or P2Y12 inhibitor unless active life-threatening bleeding 3, 4

If hypotension persists after fluid resuscitation:

• Vasopressor support with norepinephrine (preferred first-line agent)
• Avoid positive inotropes if any concern for dynamic obstruction or if patient has HCM
• Transfer to intensive care unit for continuous monitoring

Critical Medication Review

Verify dual antiplatelet therapy status:

• Patient should be on aspirin 81-325 mg daily PLUS clopidogrel 75 mg daily (or prasugrel/ticagrelor if ACS indication) 3, 4
• Premature DAPT discontinuation is the leading cause of stent thrombosis 1
• Minimum duration: 1 month for bare-metal stents, 12 months for drug-eluting stents 3, 5, 4

Check for medication interactions or recent changes:

• Proton pump inhibitors (may reduce clopidogrel efficacy)
• Recent addition of beta-blockers or other antihypertensives
• Diuretics causing volume depletion

Definitive Management Based on Etiology

If stent thrombosis confirmed:

• Emergency PCI with aspiration thrombectomy
• Consider GP IIb/IIIa inhibitor (eptifibatide, tirofiban, or abciximab) 4
• Intravascular imaging (IVUS/OCT) to identify mechanical causes (malapposition, underexpansion)

If bleeding identified:

• Transfusion to maintain hemoglobin >7-8 g/dL
• Consider holding P2Y12 inhibitor temporarily only if life-threatening bleeding
• Continue aspirin if at all possible 6
• Surgical or interventional control of bleeding source

If cardiogenic shock from MI:

• Hemodynamic support (may require intra-aortic balloon pump or mechanical circulatory support)
• Urgent revascularization

Common Pitfalls to Avoid

1. Never assume hypotension is benign in the early post-stent period—this is the highest-risk window for catastrophic complications
2. Do not stop DAPT empirically without identifying the cause of hypotension—premature discontinuation causes stent thrombosis 1
3. Do not delay cardiac catheterization if stent thrombosis is suspected—time is myocardium
4. Do not overlook retroperitoneal bleeding—it can be occult without obvious external signs
5. Do not give excessive fluids if cardiogenic shock or tamponade is suspected—echocardiography first

Risk Stratification Context

This patient is in the subacute stent thrombosis window (2 days post-procedure), when thrombosis risk is highest 6. The 2-week period after stent placement carries the greatest risk, with bare-metal stent thrombosis being "exceedingly rare" after 4 weeks 6. However, drug-eluting stents can thrombose late (up to 1.5 years), particularly with DAPT interruption 6.

Proceed with systematic evaluation, maintain DAPT unless contraindicated by active life-threatening bleeding, and have a low threshold for emergency cardiac catheterization if stent thrombosis cannot be excluded.